AI Engines For more Details: Perplexity Kagi Labs You
Gastrointestinal Disorders: Lorglumide sodium salt has been investigated for its therapeutic potential in various gastrointestinal disorders, including functional dyspepsia, irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD). As a cholecystokinin receptor antagonist, lorglumide may modulate gastrointestinal motility, reduce visceral hypersensitivity, and decrease gastric acid secretion, which could alleviate symptoms such as abdominal pain, bloating, and reflux.
Pain Management: Cholecystokinin receptors are involved in pain processing, and lorglumide sodium salt has been explored for its analgesic properties. It may exert antinociceptive effects by inhibiting the release of neurotransmitters involved in pain signaling pathways. Research suggests that lorglumide may have potential as an adjuvant therapy for chronic pain conditions, although further studies are needed to elucidate its efficacy and safety profile.
Appetite Regulation and Weight Management: Cholecystokinin plays a role in appetite regulation and satiety signaling. By blocking cholecystokinin receptors, lorglumide sodium salt may modulate appetite and food intake. It has been studied as a potential adjunctive treatment for obesity and eating disorders, although clinical data on its efficacy in this context are limited.
Pancreatitis: Cholecystokinin receptors are also present in the pancreas, where they regulate pancreatic enzyme secretion. Lorglumide sodium salt has been investigated for its potential therapeutic role in acute pancreatitis and chronic pancreatitis by modulating pancreatic exocrine function. However, more research is needed to determine its effectiveness and safety in the management of pancreatic disorders.
Psychiatric Disorders: Cholecystokinin receptors are expressed in the central nervous system, where they modulate neurotransmitter release and synaptic transmission. Lorglumide sodium salt has been studied for its effects on mood, anxiety, and stress-related disorders. Preclinical studies suggest that it may have anxiolytic and antidepressant-like effects, but further clinical trials are necessary to evaluate its efficacy and potential utility in psychiatric practice.
Cancer Therapy: Cholecystokinin receptors are overexpressed in certain types of cancer cells, including pancreatic cancer and neuroendocrine tumors. Lorglumide sodium salt has been investigated as a potential adjuvant therapy for cancer treatment by targeting cholecystokinin receptor-mediated signaling pathways. It may enhance the efficacy of conventional chemotherapy and radiotherapy regimens, although clinical data are limited, and more research is needed to assess its therapeutic potential in oncology.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Streptococcus thermophilus | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 2 | Bacteroides | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Anaerostipes | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
2 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Streptococcus oralis | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 431 | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Streptococcus sp. Marseille-Q6470 | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Alistipes dispar | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Streptococcus ilei | species | Decreases |
0 | 1 | Streptococcus sanguinis | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | [Clostridium] scindens | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Streptococcus mutans | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Streptococcus sp. A12 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Campylobacter coli | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Rothia dentocariosa | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Lancefieldella parvula | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Streptococcus pasteurianus | species | Decreases |
0 | 1 | Streptococcus cristatus | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Olsenella uli | species | Decreases |
0 | 1 | Streptococcus thermophilus | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
0 | 1 | Bacteroides uniformis ATCC 8492 | strain | Increases |
0 | 1 | Bacteroides uniformis CL03T00C23 | strain | Increases |
0 | 1 | Bacteroides uniformis CL03T12C37 | strain | Increases |
0 | 1 | Bacteroides uniformis dnLKV2 | strain | Increases |
0 | 1 | Bacteroides uniformis str. 3978 T3 i | strain | Increases |
0 | 1 | Bacteroides uniformis str. 3978 T3 ii | strain | Increases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.7 | 0.7 | |
Acne | 0.3 | -0.3 | |
ADHD | 3.9 | 0.4 | 8.75 |
Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.2 | 2.5 |
Allergic Rhinitis (Hay Fever) | 3.1 | 3 | 0.03 |
Allergies | 6.3 | 3 | 1.1 |
Allergy to milk products | 1.3 | 0.9 | 0.44 |
Alopecia (Hair Loss) | 1.7 | 0.1 | 16 |
Alzheimer's disease | 4.7 | 6.6 | -0.4 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.4 | 0.7 | 2.43 |
Ankylosing spondylitis | 3.9 | 1.2 | 2.25 |
Anorexia Nervosa | 2 | 3.3 | -0.65 |
Antiphospholipid syndrome (APS) | 1.2 | 0.1 | 11 |
Asthma | 5.1 | 2.4 | 1.13 |
Atherosclerosis | 2 | 1.5 | 0.33 |
Atrial fibrillation | 3.6 | 2 | 0.8 |
Autism | 7.9 | 8.4 | -0.06 |
Autoimmune Disease | 0.8 | 0.9 | -0.13 |
Barrett esophagus cancer | 0.4 | 0.4 | 0 |
benign prostatic hyperplasia | 0.1 | 0.1 | 0 |
Biofilm | 2.6 | 2.6 | |
Bipolar Disorder | 1.2 | 1.1 | 0.09 |
Brain Trauma | 1 | 1 | 0 |
Breast Cancer | 0.1 | 0.1 | |
Cancer (General) | 0.8 | 2.9 | -2.62 |
Carcinoma | 2.9 | 2.3 | 0.26 |
Celiac Disease | 2.5 | 3.6 | -0.44 |
Cerebral Palsy | 1.6 | 1.2 | 0.33 |
Chronic Fatigue Syndrome | 5.1 | 6.1 | -0.2 |
Chronic Kidney Disease | 3.6 | 2 | 0.8 |
Chronic Lyme | 0.6 | 0.3 | 1 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.4 | 1.2 | 1 |
Chronic Urticaria (Hives) | 1.3 | 1.3 | 0 |
Coagulation / Micro clot triggering bacteria | 0.8 | 1.5 | -0.88 |
Cognitive Function | 1.8 | 1.6 | 0.13 |
Colorectal Cancer | 5.4 | 2 | 1.7 |
Constipation | 0.7 | 0.7 | 0 |
Coronary artery disease | 2.2 | 3.1 | -0.41 |
COVID-19 | 9.3 | 13.3 | -0.43 |
Crohn's Disease | 6.4 | 4.9 | 0.31 |
Cushing's Syndrome (hypercortisolism) | 0.1 | -0.1 | |
cystic fibrosis | 0.2 | 1.7 | -7.5 |
d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
deep vein thrombosis | 1.1 | 1.1 | 0 |
Denture Wearers Oral Shifts | 1.8 | 1.8 | |
Depression | 9.2 | 7.4 | 0.24 |
Dermatomyositis | 0.4 | 0.3 | 0.33 |
Eczema | 1.8 | 2.8 | -0.56 |
Endometriosis | 2 | 1.6 | 0.25 |
Eosinophilic Esophagitis | 0.8 | -0.8 | |
Epilepsy | 3.2 | 1.4 | 1.29 |
erectile dysfunction | 0.5 | 0.3 | 0.67 |
Fibromyalgia | 2.9 | 1.5 | 0.93 |
Functional constipation / chronic idiopathic constipation | 4.2 | 4 | 0.05 |
gallstone disease (gsd) | 3.7 | 0.7 | 4.29 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.1 | 1.9 | -0.73 |
Generalized anxiety disorder | 2.1 | 1.7 | 0.24 |
giant cell arteritis | 0.3 | -0.3 | |
Glioblastoma | 0.5 | -0.5 | |
Gout | 2 | 0.4 | 4 |
Graves' disease | 1.6 | 3 | -0.88 |
Gulf War Syndrome | 1.1 | 1.8 | -0.64 |
Halitosis | 0.9 | 0.5 | 0.8 |
Hashimoto's thyroiditis | 3.2 | 1 | 2.2 |
Heart Failure | 3.3 | 2.4 | 0.38 |
hemorrhagic stroke | 0.5 | 0.5 | |
Hidradenitis Suppurativa | 0.8 | 0.4 | 1 |
High Histamine/low DAO | 1.4 | 0.6 | 1.33 |
hypercholesterolemia (High Cholesterol) | 0.8 | 0.3 | 1.67 |
hyperglycemia | 1.7 | 1.4 | 0.21 |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.2 | 3 |
hypersomnia | 0.8 | -0.8 | |
hypertension (High Blood Pressure | 3.1 | 5.7 | -0.84 |
Hypothyroidism | 0.2 | 1 | -4 |
Hypoxia | 2.1 | 2.1 | |
IgA nephropathy (IgAN) | 1.1 | 5.1 | -3.64 |
Inflammatory Bowel Disease | 8.1 | 10.2 | -0.26 |
Insomnia | 2.4 | 2.7 | -0.13 |
Intelligence | 1 | 0.5 | 1 |
Intracranial aneurysms | 1.2 | 0.2 | 5 |
Irritable Bowel Syndrome | 6.4 | 3.8 | 0.68 |
ischemic stroke | 2.8 | 0.7 | 3 |
Liver Cirrhosis | 6.7 | 3 | 1.23 |
Long COVID | 6.6 | 7.5 | -0.14 |
Low bone mineral density | 0.8 | -0.8 | |
Lung Cancer | 0.8 | 1.5 | -0.88 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.4 | 0.6 | -0.5 |
ME/CFS with IBS | 0.9 | 2.3 | -1.56 |
ME/CFS without IBS | 1.9 | 2.1 | -0.11 |
membranous nephropathy | 0.4 | 0.4 | |
Menopause | 2.5 | 0.5 | 4 |
Metabolic Syndrome | 6.6 | 6.8 | -0.03 |
Mood Disorders | 10 | 6.1 | 0.64 |
multiple chemical sensitivity [MCS] | 1.6 | 0.5 | 2.2 |
Multiple Sclerosis | 6.3 | 6.7 | -0.06 |
Multiple system atrophy (MSA) | 1.6 | 1.1 | 0.45 |
myasthenia gravis | 0.4 | 0.6 | -0.5 |
neuropathic pain | 0.1 | 2.3 | -22 |
Neuropathy (all types) | 1 | 1.2 | -0.2 |
neuropsychiatric disorders (PANDAS, PANS) | 0.8 | 0.8 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 5 | 4.9 | 0.02 |
NonCeliac Gluten Sensitivity | 1.4 | 0.4 | 2.5 |
Obesity | 9.3 | 7.2 | 0.29 |
obsessive-compulsive disorder | 4.8 | 3.8 | 0.26 |
Osteoarthritis | 3 | 1.3 | 1.31 |
Osteoporosis | 1.5 | 1.7 | -0.13 |
pancreatic cancer | 0.7 | 0.4 | 0.75 |
Parkinson's Disease | 7.2 | 7.1 | 0.01 |
Polycystic ovary syndrome | 5.4 | 3.2 | 0.69 |
Postural orthostatic tachycardia syndrome | 0.3 | 0.3 | 0 |
Premenstrual dysphoric disorder | 1 | 0.2 | 4 |
primary biliary cholangitis | 1.1 | 1 | 0.1 |
Primary sclerosing cholangitis | 3 | 3.6 | -0.2 |
Psoriasis | 4.1 | 2.6 | 0.58 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 6.8 | 4 | 0.7 |
Rosacea | 0.8 | 0.6 | 0.33 |
Schizophrenia | 6.7 | 2.8 | 1.39 |
scoliosis | 0.3 | 0.8 | -1.67 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 3.1 | 2.4 | 0.29 |
Sleep Apnea | 1.4 | 1 | 0.4 |
Slow gastric motility / Gastroparesis | 0.9 | 0.3 | 2 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.5 | 0.5 | 2 |
Stress / posttraumatic stress disorder | 1.9 | 1.5 | 0.27 |
Systemic Lupus Erythematosus | 3.7 | 2.1 | 0.76 |
Tic Disorder | 1 | 1.8 | -0.8 |
Tourette syndrome | 0.8 | 0.1 | 7 |
Type 1 Diabetes | 3.8 | 3.4 | 0.12 |
Type 2 Diabetes | 6.8 | 5.7 | 0.19 |
Ulcerative colitis | 5.1 | 6.3 | -0.24 |
Unhealthy Ageing | 3.6 | 1.9 | 0.89 |
Vitiligo | 2 | 1.1 | 0.82 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]